• 1.Department of Thoracic Surgery, Cancer Center, Sun Yat-sen University, Guangzhou 510060, P. R. China;;
  • 2. Lung Cancer Research Center, Sun Yat-sen University, Guangzhou 510060, P. R. China;;
  • 3. State Key Laboratory of Oncology in South China,Guangzhou 510060, P. R. China;
Export PDF Favorites Scan Get Citation

Abstract: Pulmonary metastasectomy is an option for patients with metastatic tumor of lung. Numerous retrospective
studies have demonstrated that complete control of primary tumor and complete resection of metastases limited to the
lungs may be associated with prolonged survival. Speci?c issues require consideration when planning pulmonary metastasectomy. Regardless of histological type of primary tumor, complete resection is the most important prognostic factor. The other two important prognostic factors are long disease interval and limited number of metastatic tumor of lung. Hand-assisted thoracoscopic surgery for bilateral lung metastasectomy through sternocostal triangle access is recommended. Pulmonary hilar and mediastinal lymph node metastases are some relative contraindications for this surgery. Nowdays preoperative imaging examinations still have limitations in detecting all the lung metastases. Some data emphasize the importance of considering patients for extended resection in metastatic tumor of lung. Repeat resection after previous metastasectomies can be of benefit under certain circumstances so we should remove as little healthy lung tissue as possible. In this review, we discuss about some disputed issues in order to establish a useful criterion for consideration of pulmonary metastasectomy.

Citation: ZHENG Yan,LONG Hao.. Surgical Strategy of Pulmonary Metastases: Clinical Evidence. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2012, 19(1): 62-72. doi: Copy